Effects of chemotherapy and blocking activin receptor signaling on skeletal muscle size, oxidative capacity and function
Introduction. Doxorubicin (DOX) is widely used as a chemotherapy drug for cancer. However, it is known to affect negatively skeletal muscle mass and function, which can expose to other diseases and decrease survival rate. Presently, there are no accepted drugs for muscle wasting, but myostatin and a...
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , |
| Aineistotyyppi: | Pro gradu |
| Kieli: | eng |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://jyx.jyu.fi/handle/123456789/50573 |